-
Oxford joins consortium to advance quantum drug discovery
pharmatimes
January 11, 2022
The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.
-
NRx Pharmaceuticals and Quantum Leap With Treatment of Severely Ill COVID-19 Patients with ZYESAMIÔ
americanpharmaceuticalreview
July 14, 2021
NRx Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative™ have begun treating patients with inhaled ZYESAMIÔ (Aviptadil), in the I-SPY COVID Trial (NCT04488081), a phase 2 adaptive platform trial aimed at improving treatment for severely ...
-
Quantum Collaborates With Supermicro to Expand Reach of Next-Gen Object Storage Software
prnewswire
June 25, 2021
Quantum Corporation (NASDAQ: QMCO) is collaborating with global enterprise computing leader Supermicro® to deliver object storage solutions to customers demanding the ability to extract more value from their increasing data stores.
-
Quantum Leap Healthcare Discontinues Razuprotafib I-SPY COVID Trial
americanpharmaceuticalreview
March 11, 2021
Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio drug, razuprotafib.
-
Immunotherapy specialist benefits from Quantum bioprocessing pump
europeanpharmaceuticalreview
July 18, 2019
Quantum pump specified for critical UF/DF processes; user says “no other pump could meet all of our needs”.
-
Quantum dots to shine bright with ROMIL solvents
europeanpharmaceuticalreview
May 07, 2019
Quantum dots to shine bright with ROMIL solvents...
-
Shanghai ChemPartner closes deal with Quantum
biospectrumasia
August 20, 2018
Michael Hui will remain the Chairman of the Shanghai ChemPartner, and will serve as the Vice Chairman of the Quantum Board of Directors.